Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes

In view of the occurrence of diabetic ketoacidosis associated with the use of sodium‐glucose transport protein‐2 inhibitors in patients with type 1 diabetes (T1DM) and the relative absence of this complication in patients treated with liraglutide in spite of reductions in insulin doses, we investiga...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes, obesity & metabolism obesity & metabolism, 2017-09, Vol.19 (9), p.1306-1311
Hauptverfasser: Garg, Manisha, Ghanim, Husam, Kuhadiya, Nitesh D., Green, Kelly, Hejna, Jeanne, Abuaysheh, Sanaa, Torre, Barrett, Batra, Manav, Makdissi, Antoine, Chaudhuri, Ajay, Dandona, Paresh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!